Pharmaceutical Regulatory Affairs in the Middle East

This seminar will provide you with an essential overview of the key areas of pharmaceutical regulatory affairs in the Middle East.

18-19 Jun 2018

GBP 1,499
EUR 2,099
USD 2,338

Book now

Course overview

Countries to be covered include: Bahrain, Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon, Libya, Oman, Palestine, Qatar, Saudi Arabia, Sudan Syria, UAE, Yemen

BENEFITS OF ATTENDING THIS MEETING

  • Gain an Overview of the Regulatory Environment in the Middle East
  • Understand the Economic and Cultural Background to the Markets
  • Clarify Procedures for Company and Product Registration
  • Discuss Harmonisation and Recent Developments in the Region
    • Centralised Registration in the Gulf (GCC-DR)
    • Middle East Regulatory Conference (MERC)
    • MERC Follow-up Activities
    • Industry Regulatory Groups and Activities

Why you should attend

This seminar will provide you with an essential overview of the key areas of regulatory affairs in the Middle East. This two day course will focus on practical aspects to assist with regulatory affairs in the region. The course will include interactive discussion sessions to allow you to exchange experiences with other delegates.

Who should attend

This seminar will be of particular interest to:

  • Anyone involved in pharmaceutical regulatory affairs in the Middle East
  • Anyone new to the region
  • Anyone interested in an update of recent developments

Programme

This course will cover regulatory activities in- Bahrain, Egypt, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Libya, Oman, Palestine, Qatar, Saudi Arabia, Sudan, Syria, UAE, Yemen

Each country presentation will cover the following topics:-

*The Pharmaceutical Regulatory Environment

  • Markets and Culture
  • Healthcare
  • Business Culture
  • Regulatory Environment and Characteristics
  • General Regulatory Requirements
  • Company and Product Registration
  • Variations and Renewals
  • Drug Classification
  • Regulatory Summary

Economic Overview of the Middle East

  • Population and GDP per capita
  • Unemployment rate
    GDP Real Growth Rate
    • Inflation Rate
    • Healthcare spend per capita

Following the country presentations, there will be presentations updating on developments in the Middle East as a region

Harmonisation and Recent Developments in the Region

  • Centralised Registration in the Gulf (GCC-DR)
  • Middle East Regulatory Conference (MERC)
  • MERC Follow Up Activities
  • Industry Regulatory Groups and Activities

Discussion will take place throughout the 2 days

Presenters

Ilona Putz

Ilona Putz founded PULONA Emerging Markets based in the UAE which is dedicated to creating and developing tailor-made business concepts for clients in the healthcare sector across the Middle East. She has worked in the pharmaceutical industry since 1988 for companies like MSD, SmithKline Beecham, Karl Engelhard and HEXAL where she has held the position of Regulatory Affairs Regional Manager, responsible for regulatory affairs and later on in commercial operations for countries in the Middle East and Africa. Between 2005 and August 2008 she was Regional Head, Middle East, for Sandoz International, Germany, responsible for all commercial and business development activities.
She consults also for RegAff for the Middle East which is the only Global Specialist Regulatory Affairs company with a broad geographical coverage, and for Emergo Group, which is a global consultancy company for Medical Devices. She spoke also for DIA (Drug Information Association) Switzerland on “Clinical Trials in the Middle East”, DIA Europe Meeting, Geneva 2011.

Heba Hashem

Heba has been working with Regulatory Affairs in the Middle East for more than 25 years. She has a Pharmaceutical and Business background being a graduate of the Faculty of Pharmacy (Cairo University), RAC certified in addition to an MBA at Maastricht School of Business. For the past 20 years Heba held the position of Middle East & Africa Regulatory and Quality Head at different Pharmaceutical and Medical Device companies; Gambro, Bayer and Novo Nordisk.

Heba is now the Middle East and Africa Associate Director at PPD where she is providing regulatory consulting services and training to Health Care companies.

Book now

18-19 Jun 2018
18-19 Jun 2018 Rembrandt Hotel, London GBP 1,499.00
EUR 2,099.00
USD 2,338.00
+ VAT @ 20.00%
Enrol now

You may also be interested in

Previous customers include...

  • Acino Pharma AG
  • Actelion Pharmaceutical Ltd
  • Amdipharm Limited
  • Aptar France SAS
  • Chiesi Farmaceutici SPA
  • DDD LTD
  • Ego Pharmaceuticals Pty Ltd
  • Forest Laboratories UK Ltd
  • Galderma International
  • Ginsana SA
  • Grunenthal GmbH
  • GW PHARMACEUTICALS PLC
  • Janssen Pharmaceutica NV
  • Laboratorios CINFA SA
  • Leo Pharmaceutical Products Sarath Ltd
  • Martindale Pharma
  • Medicines and Healthcare Products Regulatory Agency (MHRA)
  • Medochemie Limited
  • MEDRAD Europe BV
  • Ministry of Defence
  • Novartis Consumer Health SA
  • Nutricia Ltd
  • Pharmalex GmbH
  • Reckitt Benckiser Healthcare (UK) Ltd
  • Sanofi Winthrop Industrie
  • Shire International GmbH
  • Tarius A/S
  • Tillotts Pharma AG
  • UCB Pharma SA
  • Zentiva ks